论文部分内容阅读
脑梗塞的理想治疗应当是:溶栓治疗窗内的有效溶栓治疗,保证缺血区的再灌流,细胞保护窗的有效治疗,减少缺血区的神经元死亡和缺血神经元的唤醒等综合治疗。目前临床上采用的治疗方案是:6小时内的溶栓治疗,6小时后的抗凝、血液稀释、抗脑水肿以及自由基清除剂、钙通道阻滞剂和血管活性物质。 降纤酶是一种新型单成分降粘、化纤、溶栓药物,具有纯度高、副作用小、疗效可靠、安全性好等特点,为进一步观察疗效,我们对其治疗脑梗塞急性期进行了初步的临床观察,现将结果报告如下。
Ideally, the treatment of cerebral infarction should be: effective thrombolytic therapy in thrombolytic therapy window to ensure reperfusion in ischemic area, effective treatment of cytoprotective window, reduction of neuronal death in ischemic area and arousal of ischemic neurons Comprehensive Treatment. The current clinical treatment options are: thrombolytic therapy within 6 hours, anticoagulation after 6 hours, hemodilution, anti-brain edema and free radical scavengers, calcium channel blockers and vasoactive substances. Defibrase is a new type of single component viscosity reducing, chemical fiber, thrombolytic drugs, with high purity, side effects, reliable, safe and so on. In order to further observe the curative effect, we have carried out preliminary treatment of acute stage of cerebral infarction The clinical observations, the results are reported below.